Document is current
Any future updates will be listed below
-
Authors
Maaniitty, Eveliina
Jalkanen, Juho
Sinisilta, Sami
Gunn, Jarmo
Vasankari, Tuija
Biancari, Fausto
Jalkanen, Sirpa
Airaksinen, K. E. Juhani
Hollmen, Maija
Kiviniemi, Tuomas
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03444259 at ClinicalTrials.govDocuments that mention this clinical trial
Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease
https://doi.org/10.1038/s41598-024-68333-7
Red blood cell transfusion induces abnormal HIF-1α response to cytokine storm after adult cardiac surgery
https://doi.org/10.1038/s41598-021-01695-4
-
Funding
Funding for this research was provided by:
Finnish Foundation for Cardiovascular Research
Suomen Kardiologinen Seura
Finnish Medical Foundation
State Research Funding
- License Information
-
More Information
Article History
Received: 9 January 2024
Accepted: 22 July 2024
First Online: 27 July 2024
Competing interests
: Dr. K.E. J. Airaksinen has received speaker fees from Bayer, Pfizer, and Boehringer Ingelheim, and has been a member of the advisory boards of Bayer, Pfizer, and Astra-Zeneca. Other authors declare no potential conflict of interest.
